GlassScriptPhysician profile
Young J Cho
NPI 1154359891
$4,791.84
in general payments reported to CMS, 2019-2025
46 companies · $967 in 2025
The $967 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $40.91 · 2021: $206 · 2022: $1,025 · 2023: $883 · 2024: $1,031 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,881.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,087.86 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $786.19 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $520.99 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $390.76 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $234.94 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $214.78 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $181.80 | 2019-2025 | Tavneos |
| Galderma Laboratories, L.P. | $141.50 | 2019 | |
| Pfizer INC. | $98.45 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $89.88 | 2019-2022 | |
| Ibsa Pharma INC. | $86.28 | 2022-2025 | Tirosint, Tirosint, Licart |
| Glaxosmithkline, LLC. | $74.86 | 2023-2025 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $66.66 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $55.77 | 2022-2023 | Seglentis, Livalo |
| Boston Scientific Corporation | $48.84 | 2024 | Watchman Flx |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.